Kevin C Tang's Net Worth
Kevin C Tang's net worth is estimated to be at least $168,997,491.85 as of 05/03/2024. CoreStreet's estimation of Kevin C Tang's net worth is based on their sale of stock and current holding of stock.
Kevin C Tang is Major Shareholder at Rain Therapeutics Inc. They have executed at least 25 trades of stock as per SEC Form 4 filings. Their most recent trade was for 40,132 units of RAIN stock on 12/18/2023. Their biggest sale was on 09/12/2018 when they sold 2,695,000 units of Heron Therapeuti stock for $96,346,250.00. They typically trade 3 times per year.
Total value of insider buys:
- $67,594,477.98
Total value of insider sells:
- $101,403,013.87
Most recent insider trade:
- Dec. 18, 2023
Kevin C Tang's Insider Trading History
| Rain Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 18, 2023 | Major Shareholder | 40,132 | $1.21 | Sell | $48,559.72 |
Dec. 15, 2023 | Major Shareholder | 109,435 | $1.20 | Sell | $131,322.00 |
Oct. 13, 2023 | Major Shareholder | 131,631 | $0.99 | Buy | $130,314.69 |
Oct. 11, 2023 | Major Shareholder | 74,812 | $0.97 | Buy | $72,567.64 |
June 1, 2023 | Major Shareholder | 333,325 | $1.11 | Buy | $369,990.75 |
May 30, 2023 | Major Shareholder | 588,768 | $1.03 | Buy | $606,431.04 |
| Tcr2 Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 25, 2023 | Major Shareholder | 50,000 | $1.72 | Buy | $86,000.00 |
May 12, 2023 | Major Shareholder | 6,183 | $1.95 | Buy | $12,056.85 |
May 10, 2023 | Major Shareholder | 6,774 | $1.95 | Buy | $13,209.30 |
May 8, 2023 | Major Shareholder | 57,073 | $1.95 | Buy | $111,292.35 |
May 5, 2023 | Major Shareholder | 166,823 | $1.92 | Buy | $320,300.16 |
May 3, 2023 | Major Shareholder | 18,513 | $1.85 | Buy | $34,249.05 |
| Jounce Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 13, 2023 | Major Shareholder | 65,701 | $0.99 | Buy | $65,043.99 |
| Aptevo Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 22, 2021 | Major Shareholder | 255,331 | $7.03 | Sell | $1,794,976.93 |
Nov. 18, 2021 | Major Shareholder | 369,533 | $8.34 | Sell | $3,081,905.22 |
Nov. 6, 2020 | Major Shareholder | 174,277 | $22.73 | Buy | $3,961,316.21 |
Nov. 4, 2020 | Major Shareholder | 636,675 | $14.35 | Buy | $9,136,286.25 |
| Heron Therapeuti | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 4, 2019 | Director | 285,714 | $17.50 | Buy | $4,999,995.00 |
Sept. 12, 2018 | Director | 2,695,000 | $35.75 | Sell | $96,346,250.00 |
March 29, 2018 | Director | 192,308 | $26.00 | Buy | $5,000,008.00 |
Jan. 19, 2017 | Director | 2,459,016 | $12.20 | Buy | $29,999,995.20 |
June 10, 2015 | Director | 121,212 | $24.75 | Buy | $2,999,997.00 |
June 2, 2015 | Director | 150,000 | $20.62 | Buy | $3,093,000.00 |
June 25, 2014 | Director | 510,638 | $11.75 | Buy | $5,999,996.50 |
| Cyclacel Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 23, 2017 | Major Shareholder | 134,200 | $4.34 | Buy | $582,428.00 |